Bowen Jiang

Title: The Innovative Contributions of Bowen Jiang

Introduction

Bowen Jiang is a notable inventor based in White Plains, NY (US). He has made significant contributions to the field of biotechnology, particularly in the characterization of viral vectors. His work is essential for advancing our understanding of adeno-associated viruses and their applications in gene therapy.

Latest Patents

Bowen Jiang holds a patent titled "Characterization of adeno-associated virus using microchip capillary electrophoresis." This patent involves methods and systems for identifying capsid viral proteins in a sample containing viral vectors. The innovative techniques include determining the ratio of capsid viral proteins of adeno-associated virus. The methods comprise denaturing the capsid viral proteins in the sample, labeling the denatured capsid viral proteins with a lysine-conjugation dye, generating a separation profile of the denatured/labelled capsid viral proteins using microchip capillary electrophoresis, quantifying levels of the capsid viral proteins based on the separation profile, determining a quantification ratio of the capsid viral proteins based on the separation profile, and normalizing the quantification ratio based on lysine contents of the capsid viral proteins. Bowen Jiang has 1 patent to his name.

Career Highlights

Bowen Jiang is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to contribute to innovative research in biotechnology. His work at Regeneron has positioned him as a key player in the development of therapeutic solutions that leverage viral vectors.

Collaborations

Some of his notable coworkers include Franco Tzul and Dingjiang Liu. Their collaborative efforts enhance the research environment and foster innovation within their projects.

Conclusion

Bowen Jiang's contributions to the field of biotechnology, particularly through his patent on adeno-associated viruses, highlight his role as an influential inventor. His work continues to pave the way for advancements in gene therapy and viral vector research.